Oncology

At Medniqa, we believe quality healthcare is a fundamental right, not a privilege. We’re dedicated to ensuring that even the most remote communities have access to life-saving pharmaceutical products. We exist to turn pharmaceutical potential into patient impact.

Corporate Identity Number: U51391GJ2022PTC131260

Oncology

Abiraterone acetate

Afatinib Dimaleate

Albumin Bound Paclitaxel

Aminocaproic Acid

Aprepitant

Azacitidine

Bortezomib

Calcium Folinate Hydrate

Carfilzomib

Carmustine

Docetaxel

Enzalutamide

Fosaprepitant Dimeglumine

Fulvestrant

Granisetron HCL

Imatinib Mesylate

Solutions

Services

Resources:

Partner with Us: